Annual Drug Patent Expirations for OJJAARA
Ojjaara is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has eigthy patent family members in thirty-five countries.
The generic ingredient in OJJAARA is momelotinib dihydrochloride. One supplier is listed for this compound. Additional details are available on the momelotinib dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
